Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS project

Author

Sánchez Peña, Enric

Lecube Torelló, Albert

Betriu i Bars, M. Àngels

Hernández, Cristina

López Cano, Carolina

Gutiérrez Carrasquilla, Liliana

Kerkeni, M.

Yeramian Hakim, Andree

Purroy Garcia, Francisco

Pamplona Gras, Reinald

Farràs-Sallés, Cristina

Fernández i Giráldez, Elvira

Barbé Illa, Ferran

Simó, Rafael

Publication date

2020-01-29T13:27:33Z

2020-12-31T23:15:30Z

2019-12-01

2020-01-29T13:27:38Z



Abstract

This work was supported by grants from the Lleida Provincial Council, Renal Foundation Jaume Arnó, Instituto de Salud Carlos III (ISCIII, PI 12/00803 and PI 15/00260) and European Union [European Regional Development Fund (Fondo Europeo de Desarrollo Regional, Una manera de hacer Europa)]. CIBER de Diabetes y Enfermedades Metabólicas Asociadas and CIBER de Enfermedades Respiratorias are initiatives of the Instituto Carlos III. These funders had no role in the study design, data collection or analysis, the decision to publish or preparation of the manuscript. Also, the authors would like to thank Eva Castro, Virtudes María, Teresa Molí, Teresa Vidal, Cristina Dominguez, Marta Elias, Núria Sans and Meritxell Soria for their efforts in the accurate development of the ILERVAS project.

Document Type

Article
Accepted version

Language

English

Subjects and keywords

Pulmons -- Malalties; Glucosa

Publisher

Elsevier

Related items

Versió postprint del document publicat a: https://doi.org/10.1016/j.diabet.2018.04.002

Diabetes & Metabolism, 2019, vol. 45, núm. 6, p. 595-598

Rights

cc-by-nc-nd (c) Elsevier, 2019

http://creativecommons.org/licenses/by-nc-nd/4.0/

This item appears in the following Collection(s)